EBMcalc Logo
   INTRO    EQUATIONS    CRITERIA    DECISION TREES    CONVERTERS    SPECIALTIES    OPTIMIZERS    MATHCALC    EHR CONNECT    REFS    SEARCH    NEW!
 
 
  Cardiovascular Risk Assessment (10-year, ACC/AHA 2013)

 
Input:
 
Race African American

White

Other (see notes)
Sex Female

Male
Age  
Total Cholesterol  
HDL Cholesterol  
Systolic Blood Pressure  
On Hypertension Med No

Yes
Diabetes No

Yes
Smoker No

Yes
Results:
 
Ten Year Risk  
 
Decimal Precision  

 
     
 

 
Notes

 
References
  1. Goff DC Jr, Lloyd-Jones DM, Bennett G, et.al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Nov 12. PMID: 24222018 PubMed Logo
  2. Stone NJ, Robinson J, Lichtenstein AH, et. al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Nov 12. PMID: 24222016 PubMed Logo
  3. Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013 Nov 30;382(9907):1762-5. doi: 10.1016/S0140-6736(13)62388-0. Epub 2013 Nov 20. PMID: 24268611 PubMed Logo
  4. Downs J, Good C. New Cholesterol Guidelines: Has Godot Finally Arrived?. Ann Intern Med. 2014 Jan 28. doi: 10.7326/M13-2850. PMID: 24473934 PubMed Logo
  5. Vaishnava P, Eagle KA. ACP Journal Club. ACC/AHA, Adult Treatment Panel III, and ESC guidelines overestimated risk for CVD in older adults. Ann Intern Med. 2014 Aug 19;161(4):JC13. PMID: 25133380 PubMed Logo
  6. Kavousi M, Leening MJ, Nanchen D, et. al. Comparison of Application of the ACC/AHA Guidelines, Adult Treatment Panel III Guidelines, and European Society of Cardiology Guidelines for Cardiovascular Disease Prevention in a European Cohort. JAMA. 2014 Mar 29. doi: 10.1001/jama.2014.2632. PMID: 24681960 PubMed Logo
  7. Navar-Boggan AM, Newby LK. ACC/AHA Pooled Cohort Risk Equations predicted 5-y risk for CV events in adults considered for statin initiation. Ann Intern Med. 2014 Aug 19;161(4):JC12. PMID: 25133379 PubMed Logo
  8. Muntner P, Colantonio LD, Cushman M, et. al. Validation of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations. JAMA. 2014 Mar 29. doi: 10.1001/jama.2014.2630. PMID: 24682252 PubMed Logo
  9. DeFilippis AP, Young R, Carrubba CJ, et. al. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med. 2015 Feb 17;162(4):266-75. PMID: 25686167 PubMed Logo
  10. Ridker PM, Cook NR. Comparing cardiovascular risk prediction scores. Ann Intern Med. 2015 Feb 17;162(4):313-4. PMID: 25686171 PubMed Logo
  11. Pursnani A, Massaro JM, D'Agostino RB Sr, et. al. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events. JAMA. 2015 Jul 14;314(2):134-41. PMID: 26172893 PubMed Logo
  12. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, et. al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016 Nov 15;316(19):1997-2007. PMID: 27838723 PubMed Logo

 
Associated Medical Subject Headings [MeSH] Terms
 
         80 and over,   Aged,   American Heart Association,   Anticholesteremic Agents,   Antihypertensive Agents,   Aspirin,   Atherosclerosis,   Calcinosis,   Calibration,   Cardiology,   Cardiovascular Diseases,   Cholesterol,   Cohort Studies,   Continental Population Groups,   Coronary Artery Disease,   Diabetes Complications,   Female,   Follow-Up Studies,   Humans,   Hydroxymethylglutaryl-CoA Reductase Inhibitors,   Hypercholesterolemia,   Hyperlipidemias,   Hypolipidemic Agents,   Incidence,   Interviews as Topic,   Kaplan-Meier Estimate,   LDL,   Longitudinal Studies,   Male,   Mathematical Concepts,   Medical,   Middle Aged,   Models,   Myocardial Revascularization,   Patient-Centered Care,   Platelet Aggregation Inhibitors,   Practice Guidelines as Topic,   Primary Prevention,   Prospective Studies,   Risk,   Risk Assessment,   Risk Factors,   Secondary Prevention,   Sex Factors,   Societies,   Stroke,   Theoretical,   Time Factors,   Voluntary Health Agencies,   World Health

 
Associated Logical Observation Identifiers Names and Codes [LOINC]
 
Parameter LOINC's and Units
Age 21612-7 : Years old      21612-7 : yr      21612-7 : years      30525-0 : Years old      30525-0 : yr      30525-0 : years      
Total Cholesterol 2093-3 : mg/dL      14647-2 : mmol/L      
HDL Cholesterol 2085-9 : mg/dL      14646-4 : mmol/L      

 
This material contains content from LOINC® (http://loinc.org). The LOINC table, LOINC codes, and LOINC panels and forms file are copyright © 1995-2014, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and available at no cost under the license at http://loinc.org/terms-of-use.

 
Associated ICD9-CM Codes
 
   434.0Cerebral thrombosis
   437.0Cerebral atherosclerosis
   401Essential hypertension
   401.1Benign hypertension
   272.2Mixed hyperlipidemia
   272.4Hyperlipidemia nec/nos
   414.0Coronary atherosclerosis
   414.4Coronary atherosclerosis

 
Legal Notices and Disclaimer

 
All information contained in and produced by the EBMcalc system is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease. THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER. Click here for full notice and disclaimer.
 
MedCalc 3000 is Copyright © 1998-2017 Foundation Internet    [Build 252309 v17.1]